IndraLab

Statements

(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[[[(1S)-1-carboxy-2-phenylethyl]amino]-oxomethyl]-1-pyrrolidinyl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid inhibits MAPK8. 1 / 1
| 1
reach
"Morever, unilateral ureter obstruction activates JNK1 in an AngII dependent manner as demonstrated by the ability of the angiotensin type 1 receptor blocker candesartan to diminish JNK1 activation and to decrease renal fibrosis XREF_BIBR."
19782079